Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy 2010

More information on Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy

The Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy congress will address emerging data that underlie the optimal management of early-stage and locally advanced breast cancer. The congress will include an in-depth discussion of the increasing number of breast cancer subtypes that challenge oncologists. A significant emphasis on case discussions and new data supporting adjuvant and neoadjuvant treatment options will provide a forum for discussion of the practical applicability of evolving clinical trial findings. Other topics pertaining to predictive biomarkers, staging, risk assessment, toxicity management, and survivorship will also be addressed.

The purpose of this congress is to provide an update on the latest advances in the management of early-stage and locally advanced breast cancer and to address key areas of controversy concerning treatment in those settings.